Campylobacter Gastroenteritis (Campylobacter jejuni)
For the why behind the fact
Use this page to connect what you are memorizing.
Start with the overview when a class slide, Anki card, or qbank explanation feels too thin. Then use presentation and workup to recognize the condition, and differentials to separate look-alikes.
Overview
Plain-Language Overview
Campylobacter Gastroenteritis is an infection that affects the digestive system, specifically the intestines. It is caused by the bacteria Campylobacter jejuni, which is commonly found in contaminated food or water. This infection leads to symptoms such as diarrhea, often bloody, abdominal pain, fever, and sometimes nausea or vomiting. The bacteria cause inflammation in the intestines, which disrupts normal digestion and absorption. Most people recover within a week, but the illness can be more severe in young children, the elderly, or those with weakened immune systems. The main health impact is dehydration due to diarrhea and the discomfort from intestinal inflammation.
Clinical Definition
Campylobacter Gastroenteritis is an acute infectious enteritis caused primarily by the gram-negative, curved rod bacterium Campylobacter jejuni. The pathogenesis involves bacterial invasion of the intestinal mucosa, leading to inflammation and mucosal damage predominantly in the ileum and colon. This results in symptoms of bloody diarrhea, fever, and abdominal cramping. The infection is a common cause of bacterial gastroenteritis worldwide and is typically transmitted via ingestion of contaminated poultry, unpasteurized milk, or water. The clinical significance includes potential complications such as Guillain-Barré syndrome and reactive arthritis. Diagnosis is important to differentiate from other causes of infectious diarrhea and to guide management.
Inciting Event
Ingestion of contaminated food or water containing Campylobacter jejuni initiates infection.
Consumption of raw or undercooked poultry is the most common source of exposure.
Contact with infected animals or their feces can lead to transmission.
Cross-contamination during food preparation facilitates bacterial spread.
Latency Period
Symptoms typically develop 2 to 5 days after ingestion of contaminated material.
The incubation period is usually 2–5 days, with a broader reported range of 1–10 days.
Incubation varies with exposure and host factors; immunocompromise predicts more severe/prolonged disease, not a reliably shorter diagnostic window.
Diagnostic Delay
Initial symptoms often mimic viral gastroenteritis, leading to misdiagnosis.
Lack of routine stool culture for Campylobacter delays identification.
Empiric treatment without microbiologic confirmation can obscure diagnosis.
Mild cases may not seek medical attention, delaying diagnosis.
Clinical Presentation
Signs & Symptoms
Watery to bloody diarrhea is the hallmark symptom, often with mucus.
Crampy abdominal pain frequently precedes diarrhea onset.
Fever and malaise commonly accompany intestinal inflammation; they do not by themselves establish bloodstream infection.
Nausea and vomiting may occur but are less prominent.
Tenesmus and urgency can be present due to colonic inflammation.
History of Present Illness
Acute onset of fever, abdominal cramping, and watery to bloody diarrhea is typical.
Symptoms often begin with prodromal malaise and headache followed by diarrhea.
Diarrhea may be frequent and accompanied by tenesmus and urgency.
Duration of illness is usually less than one week, but can be prolonged in some cases.
Post-infectious complications such as Guillain-Barré syndrome may develop days to weeks later.
Past Medical History
History of recent travel to endemic areas increases suspicion for infection.
Document recent diarrheal illness and antibiotics to interpret recurrence, co-infection and alternative diagnoses; a prior gastroenteritis episode is not a specific diagnostic risk marker.
Use of acid-suppressing medications can increase risk of infection.
Immunosuppressive conditions or therapies may worsen disease severity.
Family History
No significant familial genetic predisposition is associated with Campylobacter jejuni infection.
Family members may share exposure risks due to common dietary or environmental sources.
Household cases may reflect a shared food, water or animal exposure; person-to-person spread is less common but possible.
Physical Exam Findings
Fever, tachycardia and volume depletion may occur. Evaluate hemodynamic severity rather than assuming dehydration is always mild or that fever proves bacteremia.
Abdominal tenderness, especially in the lower quadrants, may be present without peritoneal signs.
Hyperactive bowel sounds are often noted due to increased intestinal motility.
Hepatomegaly is not a characteristic finding of uncomplicated Campylobacter enteritis; if present, assess alternative or extraintestinal disease.
Signs of volume depletion such as dry mucous membranes and decreased skin turgor may be observed.
Diagnostic Workup
Diagnostic Criteria
A compatible diarrheal illness with a positive stool culture or validated molecular/CIDT assay supports Campylobacter infection. Test especially with bloody diarrhea, fever, severe pain, prolonged illness or high-risk hosts. Molecular assays may identify a Campylobacter group rather than prove C. jejuni specifically, and detection must be interpreted clinically. Culture can provide an isolate for susceptibility testing and public-health investigation. For Step 1, recognize motile curved gram-negative rods with microaerophilic growth, commonly at about 42°C for C. jejuni.
Pathophysiology
Key Mechanisms
Invasion of intestinal mucosa by Campylobacter jejuni leads to inflammatory diarrhea.
Production of cytotoxins causes mucosal damage and contributes to colitis.
Activation of host immune response results in recruitment of neutrophils and release of proinflammatory cytokines.
Epithelial injury and barrier disruption cause impaired absorption, fluid loss and inflammatory exudation; this is inflammatory enterocolitis, not simply a pure secretory-toxin syndrome.
Bacterial lipooligosaccharide structures can mimic nerve gangliosides, eliciting cross-reactive antibodies that trigger postinfectious Guillain-Barré syndrome in a small minority of patients.
| Involvement | Details |
|---|---|
| Organs | The distal small intestine and colon are major sites of enterocolitis; mucosal invasion and inflammation explain pain and watery or bloody diarrhea. |
Colonic involvement is part of the usual enterocolitis spectrum and does not necessarily imply bloodstream dissemination. | |
| Tissues | Intestinal mucosa is the primary site of inflammation and damage leading to diarrhea and abdominal pain. |
Lamina propria contains immune cells that mediate the inflammatory response to infection. | |
| Cells | Neutrophils mediate acute inflammatory response causing mucosal damage in the intestinal epithelium. |
Macrophages phagocytose bacteria and release proinflammatory cytokines contributing to tissue injury. | |
Enterocytes are the primary intestinal epithelial cells affected by bacterial invasion and toxin-mediated damage. | |
| Chemical Mediators | Interleukin-8 (IL-8) recruits neutrophils to the site of infection, amplifying inflammation. |
Tumor necrosis factor-alpha (TNF-α) promotes inflammation and contributes to mucosal injury. | |
Cytolethal distending toxin (CDT) produced by Campylobacter jejuni causes DNA damage and cell cycle arrest in host cells. |
Treatments
Pharmacological Treatments
Azithromycin
- Mechanism:
Inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, effective against Campylobacter jejuni.
- Side effects:
Gastrointestinal upset
QT prolongation
Allergic reactions
- Clinical role:
Preferred antibiotic when treatment is indicated for severe/prolonged infection or a high-risk patient, guided by local resistance and susceptibility when available. Most uncomplicated cases need fluids rather than antibiotics.
Fluoroquinolones
- Mechanism:
Inhibit bacterial DNA gyrase and topoisomerase IV, disrupting DNA replication in Campylobacter jejuni.
- Side effects:
Tendinitis and tendon rupture; risk is greater in older adults and with corticosteroid exposure.
QT prolongation
Gastrointestinal upset
- Clinical role:
Alternative only when susceptibility and clinical circumstances support use; fluoroquinolone resistance is common, including in the United States, so these are not a reliable routine second-line choice.
Non-pharmacological Treatments
Use oral rehydration solution for mild/moderate dehydration; severe dehydration, shock or inability to tolerate oral intake requires appropriate intravenous isotonic fluids. Continue suitable nutrition as tolerated.
Avoid antimotility drugs with bloody/inflammatory diarrhea or fever. They are not a substitute for rehydration; pediatric acute diarrhea requires particular avoidance.
Prevention
Pharmacological Prevention
No approved vaccine currently exists for Campylobacter jejuni.
Antibiotic prophylaxis is not routinely recommended due to resistance concerns.
Macrolides such as azithromycin are used for treatment but not prevention.
No effective chemoprophylaxis is established for travelers or contacts.
Rehydration and timely assessment reduce acute complications. Antibiotic treatment has not been established as reliable prevention of postinfectious GBS or reactive arthritis.
Non-pharmacological Prevention
Proper food handling and cooking to avoid ingestion of contaminated poultry or meat.
Hand hygiene with soap and water after contact with animals or raw food.
Avoidance of unpasteurized milk and untreated water sources.
Safe drinking water and sanitation reduce transmission risk.
Education on avoiding cross-contamination in kitchen environments.
Outcome & Complications
Complications
Guillain-Barré syndrome is a serious autoimmune neuropathy triggered by molecular mimicry.
Reactive arthritis can develop days to weeks after infection.
Bacteremia and systemic infection occur mainly in immunocompromised hosts.
HUS has rarely been reported with Campylobacter, but Shiga toxin-producing E. coli is the classic diarrheal association. Anemia, thrombocytopenia and kidney injury require urgent evaluation rather than automatic attribution to Campylobacter.
Intestinal perforation is uncommon but possible in severe colitis.
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Campylobacter Gastroenteritis (Campylobacter jejuni) versus Salmonella Gastroenteritis
Campylobacter Gastroenteritis (Campylobacter jejuni) | Salmonella Gastroenteritis |
|---|---|
Gram-negative curved rods, microaerophilic Campylobacter jejuni | Gram-negative bacilli, facultative intracellular bacteria of the genus Salmonella |
Consumption of undercooked poultry or unpasteurized milk | Consumption of contaminated poultry, eggs, or contact with reptiles |
Diarrhea with possible bloody stools, fever, and abdominal pain, usually self-limited within 1 week | Often self-limited diarrhea lasting 4-7 days, may cause bacteremia in immunocompromised |
Campylobacter Gastroenteritis (Campylobacter jejuni) versus Shigella Gastroenteritis
Campylobacter Gastroenteritis (Campylobacter jejuni) | Shigella Gastroenteritis |
|---|---|
Motile, gram-negative curved rods causing mucosal inflammation | Non-motile, gram-negative bacilli causing invasive colitis |
Watery or bloody diarrhea, fever, cramps and sometimes tenesmus; symptoms overlap with other invasive enteric infections. | Often prominent tenesmus and frequent small-volume stools, but watery diarrhea and variable fever also occur. |
Stool culture or a validated molecular assay detects Campylobacter; species reporting depends on the method. | Culture or CIDT can detect Shigella; some assays group Shigella with enteroinvasive E. coli. Culture supplies an isolate for susceptibility testing. |
Campylobacter Gastroenteritis (Campylobacter jejuni) versus Enterohemorrhagic Escherichia coli (EHEC) Infection
Campylobacter Gastroenteritis (Campylobacter jejuni) | Enterohemorrhagic Escherichia coli (EHEC) Infection |
|---|---|
Gram-negative curved rod, invasive organism | Gram-negative rod producing Shiga toxin, non-invasive |
Bloody diarrhea often accompanied by fever, but clinical features alone cannot identify the organism. | Severe cramps and watery-to-bloody diarrhea, often with little or no fever; fever can still occur. |
GBS and reactive arthritis are characteristic postinfectious associations; HUS is uncommon. | Shiga toxin can cause HUS, particularly with some strains and in children. Test appropriately and avoid antibiotics/antimotility drugs when STEC is suspected unless specialist guidance indicates otherwise. |
Campylobacter Gastroenteritis (Campylobacter jejuni) versus Clostridioides difficile colitis
Campylobacter Gastroenteritis (Campylobacter jejuni) | Clostridioides difficile colitis |
|---|---|
Poultry, raw milk, water and animal exposures are useful clues, but a recognized source is not required. | Antibiotic exposure or health-care contact raises risk, but community-associated infection can occur without either history. |
Watery or bloody inflammatory diarrhea with fever and cramps. | Usually watery diarrhea; pseudomembranes may occur but are not necessary for diagnosis. |
Campylobacter-positive culture or molecular testing interpreted with symptoms. | Use an appropriate toxin/NAAT testing strategy in a compatible diarrheal illness. NAAT positivity alone can reflect colonization; a negative toxin assay alone is not a universal exclusion. |
Campylobacter Gastroenteritis (Campylobacter jejuni) versus Yersinia enterocolitica Infection
Campylobacter Gastroenteritis (Campylobacter jejuni) | Yersinia enterocolitica Infection |
|---|---|
Consumption of undercooked poultry or unpasteurized milk | Consumption of contaminated pork or unpasteurized milk |
Enterocolitis can cause right lower quadrant pain and mimic appendicitis. | Terminal ileitis/mesenteric adenitis can also mimic appendicitis, often with pork exposure. |
Stool culture or molecular detection of Campylobacter with compatible symptoms. | Stool culture or validated molecular testing; notify the laboratory if suspected because specialized culture methods may be needed. |